ForecastRFI

AJ13--Liposome Preparation for Experimental Rheumatoid Arthritis treatment

Name: AJ13--Liposome Preparation for Experimental Rheumatoid Arthritis treatment
Creator: VETERANS AFFAIRS, DEPARTMENT OF
Published: 2026-07-14T00:00:00+00:00
Keywords: RFI

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF.VETERANS AFFAIRS, DEPARTMENT OF.245-NETWORK CONTRACT OFFICE 5 (36C245)

AI Overview

VA seeks vendors for custom liposomal formulation with patented joint-targeting peptides for rheumatoid arthritis drug delivery, including nanoparticle characterization and formulation validation.

This summary is AI-generated from the official solicitation.

Key Details

Agency

VETERANS AFFAIRS, DEPARTMENT OF

Funding Amount

—

Release Date

July 14, 2026

Due Date

July 31, 2026

Official Description

SOURCES SOUGHT NOTICE Joint Targeted Drug Delivery Approach for Arthritis Therapy Liposome Preparation Department of Veterans Affairs Network Contracting Office 05 (NCO 05)

Purpose The Department of Veterans Affairs (VA) is conducting market research to identify qualified and experienced sources capable of producing specialized liposomal formulations incorporating patented joint targeting technologies. This notice is issued solely for information and planning purposes and does not constit...

View on official source

Change History

Opportunity AddedJul 14, 2026 at 9:03 PM